XML 23 R5.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Balance Sheet - USD ($)
$ in Millions
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Current assets:        
Cash and cash equivalents $ 665 $ 264 $ 327 $ 595
Short-term investments   4    
Accounts receivable, net 1,011 977    
Inventories 917 861    
Prepaid expenses 54 54    
Total current assets 2,647 2,160    
Property, plant and equipment, net of accumulated depreciation of $3,175 and $3,056, respectively 2,455 2,306    
Goodwill 902 801 791  
Other intangible assets, net of accumulated amortization of $229 and $197, respectively 444 437    
Operating lease assets 173 151    
Deferred income tax assets 23 13    
Other assets 214 172    
Total assets 6,858 6,040    
Current liabilities:        
Short-term borrowings 438 82    
Accounts payable 599 504    
Accrued liabilities 421 381    
Total current liabilities 1,458 967    
Non-current liabilities 227 220    
Long-term debt 1,748 1,766    
Non-current operating lease liabilities 136 120    
Deferred income tax liabilities 217 195    
Total liabilities 3,786 3,268    
Share-based payments subject to redemption 30 31 $ 37 $ 36
Redeemable non-controlling interests 70      
Ingredion stockholders' equity:        
Preferred stock - authorized 25,000,000 shares - $0.01 par value, none issued    
Common stock - authorized 200,000,000 shares - $0.01 par value, 77,810,875 issued at December 31, 2020 and 2019, respectively 1 1    
Additional paid-in capital 1,150 1,137    
Less: Treasury stock (common stock: 10,795,346 and 10,993,388 shares at December 31, 2020 and 2019, respectively) at cost (1,024) (1,040)    
Accumulated other comprehensive loss (1,133) (1,158)    
Retained earnings 3,957 3,780    
Total Ingredion stockholders' equity 2,951 2,720    
Non-redeemable non-controlling interests 21 21    
Total equity 2,972 2,741    
Total liabilities and equity $ 6,858 $ 6,040